Potent and orally bioavailable noncysteine-containing inhibitors of protein farnesyltransferase
- 1 April 1999
- journal article
- Published by Elsevier in Bioorganic & Medicinal Chemistry Letters
- Vol. 9 (8) , 1069-1074
- https://doi.org/10.1016/s0960-894x(99)00144-4
Abstract
No abstract availableKeywords
This publication has 21 references indexed in Scilit:
- Inhibitors of protein farnesylation 1998Expert Opinion on Therapeutic Patents, 1998
- CA1A2X-competitive inhibitors of farnesyltransferase as anti-cancer agentsTrends in Pharmacological Sciences, 1997
- Ras Farnesyltransferase: A New Therapeutic TargetJournal of Medicinal Chemistry, 1997
- THE POTENTIAL OF FARNESYLTRANSFERASE INHIBITORS AS CANCER CHEMOTHERAPEUTICSAnnual Review of Pharmacology and Toxicology, 1997
- Section Review Oncologic, Endocrine & Metabolic: Farnesyl-protein transferase inhibitors in early developmentExpert Opinion on Investigational Drugs, 1996
- Farnesyltransferase inhibitors: Ras research yields a potential cancer therapeuticCell, 1994
- Protein prenylation: more than just glue?Current Opinion in Cell Biology, 1992
- PROTEIN PRENYLATION: GENES, ENZYMES, TARGETS, AND FUNCTIONSAnnual Review of Genetics, 1992
- All ras proteins are polyisoprenylated but only some are palmitoylatedCell, 1989
- ras GENESAnnual Review of Biochemistry, 1987